Inactive Instrument

Insiders TetraLogic Pharmaceuticals Corporation Other OTC

Equities

TetraLogic Pharmaceuticals Corporation Appoints Alexandre Zyngier to Board of Directors and Management	17-01-18	CI
Tetralogic Pharmaceuticals Corporation Announces Management Resignations	16-12-29	CI
TetraLogic Pharmaceuticals Corporation Announces Resignation of Douglas Reed as M. D, Effective July 21, 2016	16-07-22	CI
TetraLogic Pharmaceuticals Corporation Announces Executive Changes	16-04-07	CI
TetraLogic Pharmaceuticals Corporation Announces Resignation of Douglas E. Onsi as Member of Board of Directors, Effective February 5, 2016	16-02-03	CI
TetraLogic Pharmaceuticals Corporation Announces Resignation of Michael Steinmetz from the Board of Directors, Effective December 15, 2015	15-12-09	CI
TetraLogic Pharmaceuticals Corporation Announces Resignation of James N. Woody, M.D., Ph.D. as Director	15-03-13	CI
TetraLogic Pharmaceuticals Corporation Announces Board Appointments	14-11-07	CI
TetraLogic Pharmaceuticals Corporation Announces Board Changes	14-01-31	CI
TetraLogic Pharmaceuticals Corporation Announces Executive Changes	14-01-08	CI
TetraLogic Pharmaceuticals, Inc. Announces Changes in Executive and Management Team	13-08-19	CI
TetraLogic Pharmaceuticals, Inc. Appoints C. Glenn Begley as Senior Vice President of Research and Development	12-03-15	CI

No results for this search